Previous Article | Next Article 
Applied and Environmental Microbiology, June 2000, p. 2378-2384, Vol. 66, No. 6
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
The Macrocyclic Peptide Antibiotic Micrococcin P1 Is
Secreted by the Food-Borne Bacterium Staphylococcus equorum
WS 2733 and Inhibits Listeria monocytogenes on
Soft Cheese
Markus C.
Carnio,1
Alexandra
Höltzel,2
Melanie
Rudolf,1
Thomas
Henle,3
Günther
Jung,2 and
Siegfried
Scherer1,*
Institut für Mikrobiologie, FML
Weihenstephan, Technische Universität München, D-85354
Freising,1 Institut für
Organische Chemie, Universität Tübingen, D-72076
Tübingen,2 and Institut
für Lebensmittelchemie, Technische Universität Dresden,
D-01062 Dresden,3 Germany
Received 12 November 1999/Accepted 21 March 2000
 |
ABSTRACT |
Staphylococcus equorum WS 2733 was found to produce a
substance exhibiting a bacteriostatic effect on a variety of
gram-positive bacteria. The metabolite was purified to homogeneity by
ammonium sulfate precipitation and semipreparative reversed-phase
high-performance liquid chromatography. Electrospray mass spectrometry
confirmed the high purity of the compound and revealed a molecular mass of 1,143 Da. By two-dimensional nuclear magnetic resonance spectroscopy the substance was identified as micrococcin P1 which is a
macrocyclic peptide antibiotic that has not yet been reported for the
genus Staphylococcus. A total of 95 out of 95 Listeria strains and 130 out of 135 other gram-positive
bacteria were inhibited by this substance, while none of 37 gram-negative bacteria were affected. The antilisterial potential of
this food-grade strain as a protective starter culture was evaluated by
its in situ application in cheese-ripening experiments under laboratory
conditions. A remarkable growth reduction of Listeria
monocytogenes could be achieved compared to control cheese
ripened with a nonbacteriocinogenic type strain of Staphylococcus equorum. In order to prove that inhibition was due to micrococcin P1, a micrococcin-deficient mutant was constructed which
did not inhibit L. monocytogenes in cheese-ripening experiments.
 |
INTRODUCTION |
For production of high-quality
"red-smear cheese," complex, undefined consortia composed of many
species of bacteria and yeast from different genera are often used
(53). Most species of these consortia belong to the
"coryneform" bacteria, but many isolates have not yet been
classified. Since contamination of red smear cheese with Listeria
monocytogenes has caused considerable problems, several studies
have been performed on the antilisterial effects of coryneform bacteria
(11, 21, 30, 40, 50). Only one bacteriocin produced by
Brevibacterium linens has been characterized at the
molecular level so far (51, 52). This strain has also been
evaluated with respect to its antilisterial potential in situ on model
soft cheese under laboratory conditions (15). The
bacteriolytic substance linenscin produced by B. linens OC2 was found to inhibit L. monocytogenes, but it was not
classified as a bacteriocin (28) and its structure has never
been published.
A smaller fraction of the red-smear cheese bacteria belong to genera
other than coryneform bacteria, such as Staphylococcus or
Micrococcus. By screening the surface ripening flora of
German and French smeared cheeses with respect to their antilisterial potential, the highly inhibitory Staphylococcus equorum was
isolated from the surface of a traditional French Raclette cheese,
where it was found in cell numbers up to 108 per
cm2 (the present study).
The genus Staphylococcus is known to produce many
antibacterial substances (41, 42). According to Klaenhammer
(27), these can be classified into four main groups:
Lantibiotics (class I), low-molecular-weight antibiotic-like substances
(class II), and high-molecular-weight (100,000 to 500,000 Da)
bacteriocins (classes III and IV). Staphylococcins are class III
bacteriocins in the classical sense that are sensitive to proteolytic
enzymes, often being relatively heat stable (15 min, 120°C). In some
cases they were found to be lipoprotein-carbohydrate complexes (class IV, e.g., staphylococcin 1580). Lantibiotics, such as gallidermin, epidermin, Pep5, epicidin, or epilancin, are low-molecular-weight polypeptide antibiotics which are characterized by the presence of
unusual amino acids (lanthionine,
-methyllanthionine, forming intramolecular thioether bridges) and a high content of unsaturated amino acids (dehydroalanine and dehydrobutyrine [23, 24, 26, 44]). Class I, III, and IV molecules are ribosomally
synthesized as precursor peptides which are sometimes
posttranslationally modified and processed (26). In the
genus Staphylococcus, some low-molecular-mass (1,200 to
1,400 Da), heat-stable, but non-lanthionine-containing antimicrobial
peptides were found (class II), but their structure and their mode of
biosynthesis is thus far unknown (7).
In this study S. equorum WS 2733 was shown to produce
micrococcin P1, which is an acceptor-site-specific
inhibitor of ribosomal protein biosynthesis (12, 35)
reported for the first time in the genus Staphylococcus. A
potential application of S. equorum as a protective starter
culture was evaluated in ripening experiments performed with model soft
cheese artificially contaminated with L. monocytogenes.
 |
MATERIALS AND METHODS |
Bacterial strains, media, and bacteriocin assay.
The
micrococcin P1 producer strain S. equorum WS
2733 was isolated from French Raclette cheese using the HGMF
(hydrophobic grid membrane filter) method described previously
(11). About 20 cm2 (2 to 3 g) of the cheese
surface was scraped off aseptically, homogenized in 100 ml of sterile
Peptone-Tween diluent (containing 1.0 g of Peptone and 10.0 g
of Tween 80 per liter) and filtered through HGMF membranes filter (QA
Life Sciences, Inc., San Diego, Calif.). HGMF membranes were
transferred grid-side-up to plate count agar supplemented with 3% NaCl
(PC3+). After incubation at 30°C for 3 days, the membranes were
transferred to plates of tryptose soft agar (TB; Merck, Darmstadt,
Germany) with 8 g of agar/liter inoculated with 100 µl of a 24-h
culture of the indicator strain Listeria ivanovii (WSLC
3061) to detect inhibitory effects. Colonies corresponding to
inhibition zones were picked from the membranes and purified.
Micrococcin P1-deficient mutants were obtained by
insertional mutagenesis. The putative micrococcin synthetase gene has
been disrupted by integration of a tetracycline resistance cassette via
homologous recombination (M. C. Carnio, K. P. Francis, and S. Scherer, submitted for publication). The wild-type strain, the
micrococcin P1-deficient mutants, and the S. equorum type strain DSMZ 20674 were grown on slants of plate count
agar (Merck) at 30°C and stored at 4°C. For individual experiments,
the cells were subcultured in brain heart infusion broth (BHI; Merck)
at 30°C.
Antibacterial activity was determined by the critical dilution method
according to the method of Barefoot and Klaenhammer
(
2) and
expressed in arbitrary units (AU) per milliliter. Serial
twofold
dilutions of sterile-filtered samples in 30 mM sodium
phosphate buffer
(pH 7.0) were spotted onto tryptose soft agar
plates (TB) with 8 g
of agar/liter inoculated with 100 µl of an
overnight culture of the
indicator strain
L. ivanovii WSLC 3061
and incubated at
30°C for 24 h (spot-on-the-lawn assay). The titer
is defined as
the reciprocal of the highest dilution exhibiting
complete and clear
zones of inhibition on the indicator lawn.
L. ivanovii WSLC
3061 and
L. monocytogenes WSLC 1364 (Weihenstephan
Listeria collection) were grown as described by
Valdés-Stauber
et al. (
50).
For sensitivity screening performed with the sterile-filtered culture
supernatant, we used a variety of bacterial strains
from the
Weihenstephan Culture Collection (WS) housed at the Institute
of
Microbiology, Forschungszentrum für Milch und Lebensmittel,
Weihenstephan, Freising,
Germany.
Isolation and purification of micrococcin P1.
Micrococcin P1 was purified from 20-liter cultures of
S. equorum WS 2733 grown at 30°C in BHI broth (Merck) for
24 h. The cells were pelleted by centrifugation (12,000 × g, 20 min, 4°C). The antibiotic present in the culture
supernatant was concentrated by ammonium sulfate precipitation. The
pellet was resuspended in 650 ml of sodium phosphate buffer (50 mM, pH
7.0) and applied to a reversed-phase column (Pharmacia XK 16/70; 700 by
16 mm, silica gel 100 C18, 40 to 63 µm; Fluka)
equilibrated with buffer A (0.1% [vol/vol] trifluoroacetic acid
[TFA] H2O) at a flow rate of 1 ml/min. After a washing
with 240 ml of buffer A the column was eluted at a flow rate of 4 ml/min with increasing amounts of buffer B (80% acetonitrile-20%
H2O-0.1% TFA [vol/vol/vol]). The antibiotic-containing
fractions were collected, pooled, and redissolved in 50% ethanol
(fraction II). Final purification was achieved by reversed-phase
high-performance liquid chromatography (RP-HPLC) on an RP column
(Eurospher 100-C18, 7 µm, 250 by 8 mm; Knauer, Berlin,
Germany) equilibrated with buffer A. Micrococcin P1 was
eluted by a linear gradient of 0 to 80% buffer B in 30 min at a flow
rate of 3.5 ml/min. All purification steps were performed at room
temperature. The chromatographic equipment was obtained from
Pharmacia-LKB (Gradi-Frac System; pump, P-50; detectors, Uvicord SII
and VWM 2141; detection wavelengths, 280 and 220 nm, respectively) and
Perkin-Elmer (Liquid Chromatograph Series 400). In order to monitor
purity, sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) was performed using a discontinuous 8 to 18% gradient gel
(Excel Gel; Pharmacia-LKB). One-half of the gel was silver stained
according to the method of Blum et al. (5), while the other
half was assayed directly for antimicrobial activity by the modified
test described by Bhunia et al. (4).
GC-MS analysis.
The RP-HPLC-purified sample was hydrolyzed
under N2 atmosphere in 6 N HCl at 110°C for 24 h.
The hydrolyzate was derivatized to n-propyl esters with 3 N
HCl in n-propanol (110°C, 10 min). After completion of the
reaction the reagents were removed with N2. Reaction with
trifluoroacetic anhydride (110°C, 10 min) subsequently gave the
trifluoroacetamides. After removal of the reagents with N2,
the sample was dissolved in toluene and analyzed on a Carlo-Erba 2900 gas chromatograph (GC). The separation was performed on a fused-silica
capillary (20 by 0.25 mm, inner diameter;
df
0.13 µm) coated with
Chirasil-
-Dex (19) as stationary chiral phase. The GC was
coupled to a MAT 112S mass spectrometer (MS; Finnigan, Bremen, Germany)
with an AMD Intectra Data System. For electron-impact ionization, an
energy of 70 eV was used.
MS and NMR spectroscopy.
MS analysis was performed with
positive-ion-mode detection on a Apex II-ESI-FT-ICR MS (Bruker
Daltonics, Billerica, Mass.) operating at 4.7 T. One- and
two-dimensional nuclear magnetic resonance (NMR) experiments were
performed on a AMX2-600 spectrometer (Bruker, Karlsruhe, Germany)
operating at a proton frequency of 600.13 MHz and equipped with a 5-mm
inverse triple resonance probehead with a self-shielded Z-gradient
coil. The following experiments were recorded at 298 K using a solution
of 1.4 mg of the purified sample dissolved in 0.5 ml CD3OH:
1H NMR, TOCSY (total correlation spectroscopy), NOESY
(nuclear overhauser spectroscopy), and HSQC (heteronuclear single
quantum coherence). For suppression of the hydroxy resonance of the
solvent a Watergate sequence was appended to the homonuclear
experiments. An HMBC (heteronuclear multiple bond correlation) spectrum
was acquired at 318 K using a solution of 6 mg of the purified sample dissolved in 0.5 ml of CD3OH. HSQC and HMBC experiments
were performed with gradient selection. A 13C NMR spectrum
of the second sample was recorded on a AC250 spectrometer (Bruker,
Karlsruhe, Germany) operating at a carbon frequency of 62.90 MHz and
equipped with a 5-mm dual-probe head. Chemical shifts (see Table 2)
were referenced to the signals of the solvent at
(1H) = 3.35 ppm and
(13C) = 49.0 ppm.
Cheese-ripening experiments.
To evaluate the antilisterial
potential of the S. equorum strain WS 2733 in situ on soft
cheese, model ripening with defined single-strain cultures was
performed according to the method of Eppert et al. (15)
under laboratory conditions in glass desiccators. Micrococcin-deficient
(mic) mutants and the nonbacteriocinogenic (Bac
) S. equorum type strain DSMZ 20674 were
used as negative controls. Unripened soft cheese of the type
"Weinkäse" were obtained from a local dairy after salting and
being hand-smeared in petri dishes using gloves and 50 ml of a brine
solution with 5% NaCl inoculated with the test strain and the control
strains, respectively. The first day of smearing was designated day 1 of the ripening period. Smearing was applied five times (days 1, 3, 5, 7, and 10) at intervals of 2 or 3 days. The cheese was artificially
contaminated with L. monocytogenes WSLC 1364 (from the
Vacherin Mont d'Or outbreak) on day 1 of smearing. The contamination
levels were 4.5 × 104 CFU/ml of brine (resulting in
1.5 × 102 CFU/cm2 of cheese surface),
1.5 × 103 CFU/ml of brine (10 CFU/cm2),
and 2.0 × 102 CFU/ml of brine, respectively. The
bacterial counts of the Staphylococcus ripening culture in
the smear brine were 1.3 × 108/ml (DSMZ 20674),
1.5 × 108/ml (mic mutant), and 1.8 × 10/ml (WS 2733), respectively. In order to cope with a
potentially nonuniform distribution of listeriae on the cheese surface
at low contamination levels, a large part of the surface was
investigated for cell counts (see below).
For the determination of bacterial cell counts, one cheese for each
storage time was examined. First, 20 g of the cheese surface
(45 cm
2) was homogenized in 180 ml of 1.75% trisodium
citrate-dihydrate
solution using a stomacher. Serial decimal dilution
series of
these suspensions were plated on plate count agar
supplemented
with 3% NaCl (PC3+) for aerobic plate counts (30°C,
48 h) and
on Oxford agar (Oxoid, Hampshire, England) for listerial
counts
(37°C, 48 h). Then, 0.1 ml of each dilution was plated in
duplicate
except for the early stage of the ripening period, at which 1
ml of the initial suspension (dilution 10
1) was
distributed on 10 Oxford agar plates. The cell counts were
calculated
per square centimeter. The selective enrichment procedure
for detection
of low levels of
L. monocytogenes was performed
according to the international IDF standard 143A:1995. A total
of
25 g (equivalent to 45 cm
2) of the cheese surface was
blended with 225 ml of Tryptone soy
yeast extract broth using a
peristaltic blender. After incubation
at 30°C for 48 h, a
loopful of the enrichment culture was streaked
onto Oxford
agar.
 |
RESULTS |
Isolation of S. equorum WS 2733 and inhibitory
spectrum.
An S. equorum strain, inhibiting a variety of
L. monocytogenes strains, was isolated from the surface of a
French Raclette cheese. This bacterial consortium was composed of
approximately 7.8 × 108 CFU/cm2 (18.5%)
orange, 4.4 × 108 CFU/cm2 (10.4%)
yellow pigmented, and 2.9 × 109 CFU/cm2
(68.7%) white coryneform bacteria partly identified as B. linens and Corynebacterium fascians. The fraction of
the S. equorum strain was 2.5% (1.0 × 108
CFU/cm2) of the total aerobic plate count (4.2 × 109 CFU/cm2). The peptide antibiotic present in
the culture supernatant showed a wide spectrum of inhibitory activity
that was not restricted to closely related species (Table
1). A total of 95 out of 95 Listeria strains and 130 out of 138 other gram-positive
bacteria were inhibited. Nearly all gram-positive bacteria tested were sensitive, whereas no inhibition of 37 gram-negative bacteria was
observed. The antimicrobial peptide revealed to be highly inhibitory against all tested L. monocytogenes strains,
while only 36% of the tested Bacillus cereus strains
were sensitive. The mode of action in the tested concentrations
(12,800 AU/ml) was bacteriostatic (data not shown).
Purification of the active substance.
Purification of
micrococcin P1 was achieved by RP chromatography. The final
polishing step (RP-HPLC) resulted in a 1,600-fold increase in specific
activity with 25% recovery. The elution profile from the
RP-C18 column is presented in Fig.
1. The antimicrobial substance was eluted
at about 84% buffer B (67% acetonitrile). The strong binding of the
compound to the C18 column at relatively high acetonitrile
concentrations was indicative of a highly hydrophobic molecule. The
purification procedure was followed by SDS-PAGE analysis. A single band
was detected migrating at an Mr of <2,500 (Fig.
2A, lane 3), which is consistent with a
pure preparation and indicative of a relatively small compound. The
substance was localized in situ by its antibacterial activity. A clear
and distinct zone of inhibition (Fig. 2B), corresponding to an
Mr of <2,500 was revealed on the gel overlaid
with a L. ivanovii WSLC 3061 indicator lawn.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 1.
Elution profile of micrococcin P1 (A)
RP-HPLC on a Eurosphor 100-C18 column (250 by 8 mm; sample
volume, 10 µl; flow rate, 3.5 ml/min; linear acetonitrile gradient, 0 to 80% in 30 min) of crude concentrate (fraction II). All
contaminating compounds were separated at the beginning of the linear
gradient (0 to 60% B). (B) Analytical separation of pooled fraction
IV. The pure antibacterial compound was eluted as a distinct,
symmetrical peak at about 84% of solvent B (67% acetonitrile). The
arrow indicates the activity.
|
|

View larger version (87K):
[in this window]
[in a new window]
|
FIG. 2.
SDS-PAGE of preparations after various stages of
purification. (A) Silver-stained Excel Gel (gradient, 8 to 18% T;
Pharmacia-LKB). Lane 1, crude concentrate after ammonium sulfate
precipitation; lane 2, fraction after preparative RP-LC; lane 3, purified peptide after RP-HPLC; M, molecular weight marker SDS-7L
(Sigma); P, peptide length standard (Pharmacia-LKB). (B) Direct
detection of antilisterial activity on the gel overlaid with tryptose
soft agar seeded with the indicator strain L. ivanovii WSLC
3061. The inhibition zones after incubation overnight at 30°C
correspond to the silver-stained bands in Fig. 2A, lanes 2 and 3.
|
|
Structure.
MS analysis confirmed the purity of the sample and
revealed a molecular mass of 1,143 Da for the substance. 1H
and 13C NMR spectra (data not shown) comprised signals for
46 hydrogens (hydrogens of the three hydroxy groups exchanged fast with
the solvent) and 48 carbon atoms. Considering the molecular mass, the
moderate number of carbon and hydrogen atoms in the molecule indicated
a high content of heteroatoms. The spin systems of one valine (Fig. 3,
V), two threonine (T), and two didehydrobutyrine (Dhb) residues, as
well as of a 2-hydroxypropylamide (HPA) moiety, were traced in a TOCSY
spectrum (data not shown). Sequential connectivities between HPA and
Dhb1 and between T1 and Dhb2 (Fig.
3), respectively, were determined by a
NOESY experiment by which also the Z-configuration of both Dhb residues
was confirmed. The HSQC spectrum contained cross-peaks for eight
(hetero)aromatic methine units. Heteronuclear one-bond coupling
constants of 1JCH = 196 Hz which were
observed in the HMBC spectrum for six of the respective methine
units suggested the presence of six thiazole rings in the molecule.
Methods for detection of thiazole containing amino acids were described
for the microcin B17 structure elucidation (3).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 3.
Structure of micrococcin P1. Structural
units separated by peptide bonds are divided by dashed lines.
|
|
The GC-MS analysis of the acid hydrolyzate (data not shown) accounted
for one mole each of 1-amino-2-propanol,
L-threonine,
and
2-(1-amino-2-methylpropyl)-thiazole-4-carboxylic acid and
reflected the
structural units HPA, T
1, and V-Thia
5.
These data strongly suggested a close relationship or identity to
micrococcin P
1 (
9). The two-dimensional identity
of the
substance isolated by us with micrococcin P
1 (Fig.
3) was proven
by the complete structure elucidation of the molecule
relying
mainly on HMBC connectivities. Thereby, a detailed
assignment
of the
1H and
13C chemical shifts
was obtained (Table
2), which has
never been
published for micrococcin P
1. Apart from C-26
and C-27 of residue
T
1, the absolute configurations of the
sterocenters were not determined
experimentally but were based on
biosynthetic considerations and
assumed to be as reported for
micrococcin P
1.
Growth reduction of L. monocytogenes on cheese
surface.
The development of the pH and total aerobic plate counts
during the ripening process are shown in Fig.
4A and can be considered typical for the
ripening of industrial red-smear cheese using single-strain cultures
(15). The total aerobic plates counts of the cheese surface
before smearing were about 2.0 × 106
CFU/cm2, and the pH values were in the range of 5.0. At the
end of the ripening process all cheeses reached total aerobic cell
counts of approximately 6.0 × 108
CFU/cm2. A growth reduction of L. monocytogenes
on cheese ripened with the micrococcin P1-producing
(Mic+) S. equorum wild-type strain WS 2733 was
observed when compared to control cheese ripened with the
bacteriocin-negative strain DSMZ 20674 and the micrococcin-deficient
mutant (Mic
). The effect was dependent on the
contamination level. When challenged with 104 CFU/ml of
brine (102 CFU/cm2), a reduction of the viable
cell counts by more than 1 log unit could be observed, reaching a final
level of 8.0 × 105 CFU/cm2, while
listeriae on control cheese grew to 9.0 × 106
CFU/cm2. When challenged with 103 CFU/ml of
brine, a growth reduction of 1 to 2 log cycles could be demonstrated.
Remarkable effects could be achieved with low contamination levels
(102 CFU/ml of brine). The Listeria cells grew
to approximately 1.2 × 105 CFU/cm2 on the
control cheese ripened with the micrococcin-negative strain DSMZ 20674 (Bac
) and to 1.5 × 106
CFU/cm2 on control cheese ripened with the
micrococcin-deficient knockout mutant (Mic
), whereas on
cheese inoculated with the wild-type S. equorum WS 2733 the
growth of listeriae was completely inhibited.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 4.
Cheese ripening with defined single-strain cultures of
S. equorum WS 2733. (A) Development of pH on the cheese
surface and aerobic plate counts (PC3+ agar). (B) Growth reduction of
L. monocytogenes WSLC 1364. Listeria cell counts
on the cheese surface (Oxford agar) after contamination at day 1 with
104 CFU/ml (102 CFU/cm2) ( and
), 103 CFU/ml (10 CFU/cm2) ( and ),
and 102 CFU/ml ( and ), are shown. Control cheeses
were ripened with the micrococcin-negative type strain DSMZ 20674 (bac ), closed symbols. (C) Listeria cell counts on the
cheese surface (Oxford agar) after contamination at day 1 with
103 CFU/ml ( and ) and 102 CFU/ml (10 CFU/cm2) ( and . Control cheeses were ripened with
the micrococcin-deficient mutant (mic ), closed symbols. The
micrococcin-producing wild-type strain (mic+) is represented by open
symbols. Arrows indicate that even by using enrichment procedures,
listeriae could not be detected (n.d.). The measuring points mark the
detection limit (50 to 100 CFU/cm2) of the direct plating
method. +, Listeriae could be detected only after enrichment
procedures.
|
|
 |
DISCUSSION |
Micrococcin P1 (Fig. 3) is a macrocyclic peptide
antibiotic of the thiocillin-thiazolyl class (8, 9, 13, 25, 32, 54). Recently, a complete synthesis was published by Okumura et
al. (34). The peptide binds to complexes formed between the L11 protein of the 50S ribosomal subunit and a nucleotide sequence within the 23S rRNA and inhibits the elongation factor EFG-dependent translocation step of the growing peptide chain. Resistant mutants of
B. subtilis and B. megaterium either possess a
structurally altered 50S subunit or are specifically methylated at a
single site (nucleotide A-1067) of the 23S rRNA (39, 45,
46). It has been demonstrated that this macrocyclic thiopeptide
antibiotic is synthesized nonribosomally and involves a multifunctional
peptide synthetase, which was designated micrococcin synthase (Carnio et al., submitted).
So far, micrococcin P1 has been purified from a bacterium
related to Micrococcus varians (20, 48) and from
Bacillus pumilus (1, 16), isolated from sewage
and soil, respectively. Breiter et al. (7) have reported
antibiotically active substances excreted by seven strains belonging to
Staphylococcus and Micrococcus species isolated
from animal sources (partridge, pig, and dog). Two basic substances
were isolated and designated micrococcin M1 and M3. The physicochemical
and spectroscopic data, as well as investigations of hydrolysis
products, indicated a close relationship to micrococcin P1.
However, the structure of these compounds has never been reported. The
antibacterial substance secreted by S. equorum WS 2733 was identified as micrococcin P1 by spectroscopic evidence.
Based on biosynthetic considerations, the absolute configuration of the
sterocenters was assumed to be as reported for micrococcin P1. In this context it is of interest that other thiazole-
and oxazole-containing polypeptides such as the bacteriocin microcin B17 originate from ribosomally synthesized precursors which are posttranslationally modified (3).
S. equorum was revealed to be a potent inhibitor of growth
of L. monocytogenes on the cheese surface. The phenomenon of
complete inhibition of listeriae occurs only when the inhibitory strain is used as sole starter and when contamination with Listeria
sp. is performed in the early stage of ripening at a low concentration level (102 CFU/ml of brine), which is a high titer for
contamination occurring in the dairy industry. This is in accordance
with other studies reporting on the inhibition of Listeria
sp. on cheese surfaces (9, 14, 15, 17, 18, 29, 33, 36, 47, 49, 51, 55). The limited effects of antilisterial bacteria clearly show that there is a need for developing hurdle concepts in the dairy industry in which bacteriocinogenic bacteria play a certain role. However, such protective starters cannot replace a good hygienic practice during food processing.
Although micrococcin P1 exhibits a broad activity spectrum,
inhibiting nearly all gram-positive bacteria when tested on agar plates
(spot-on-the-lawn-assay; Table 1), the antibiotic allows the formation
of a stable ecological system on the surface of the French Raclette
cheese. However, when combined with other surface-ripening cultures in
cheese-ripening experiments under laboratory conditions, S. equorum WS 2733 dominated the ripening flora by suppressing
the other gram-positive coryneform bacteria (data not shown).
This finding may be explained by the different cheese types: on the
surface of a soft cheese the development of the ripening microflora may
be completely different from the one on the Raclette surface. It
appears, however, to be more likely that the bacterial consortium
growing on the surface of the French Raclette cheese constitutes a
well-balanced, stable ecosystem which has developed over decades of
cheese production. Biocontrol of listeriae on soft cheese by protective
ripening bacteria will therefore be more complicated than just adding
an antilisterial strain to a well-established smear-cheese flora.
S. equorum was originally isolated from the skin of healthy
horses and was first described by Schleifer et al. (43), but it has often been associated with food products. For instance, together
with Staphylococcus xylosus, it constitutes the predominant organism present during ripening of an Iberian dry cured ham
(37), contributing to the characteristic flavor of the final
product. It is also part of the ripening flora from traditional French cheeses (22) and was isolated from goat milk and cheese
(31). Moreover, 5 to 15% of the total cell counts of the
microflora of the German Tilsit cheese consist of staphylococci
classified as S. equorum (6). This species
belongs to the group of coagulase-negative staphylococci and has never
been reported to be involved in diseases. There would, therefore, be
good reason to consider S. equorum a GRAS (generally
recognized as safe) organism. In the case of our isolate, however, it
should be noted that micrococcin P1 has to be classified as
an antibiotic. With respect to its potential pharmaceutical use it may,
therefore, be wise to be careful in spreading this strain widely in the
human community before its pharmaceutical potential is evaluated.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institut
für Mikrobiologie, FML Weihen Stephan, Technische Universitat
Munchen, D-85354 Freising, Germany. Phone: 49-8161-713516. Fax:
49-8161-714512. E-mail:
Siegfried.Scherer{at}lrz.tum.de.
 |
REFERENCES |
| 1.
|
Abraham, E. P.,
N. G. Heatley,
P. Brookes,
A. T. Fuller, and J. Walker.
1956.
Probable identity of an antibiotic produced by a spore-bearing Bacillus of the B. pumilus group with micrococcin.
Nature
178:44-45.
|
| 2.
|
Barefoot, S. F., and T. R. Klaenhammer.
1983.
Detection and activity of lactacin B, a bacteriocin produced by Lactobacillus acidophilus.
Appl. Environ. Microbiol.
45:1808-1815[Abstract/Free Full Text].
|
| 3.
|
Bayer, A.,
S. Freund, and G. Jung.
1995.
Post-translational heterocyclic backbone modifications in the 43-peptide antibiotic Microcin B17, structure elucidation and NMR study of a 13C, 15N-labelled Gyrase inhibitor.
Eur. J. Biochem.
234:414-426[Medline].
|
| 4.
|
Bhunia, A. K., and M. G. Johnson.
1992.
A modified method to directly SDS-PAGE the bacteriocin of Pediococcus acidilactici.
Lett. Appl. Microbiol.
15:5-7[CrossRef].
|
| 5.
|
Blum, H.,
H. Beier, and H. J. Gross.
1987.
Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels.
Electrophoresis
8:93-99[CrossRef].
|
| 6.
|
Bockelmann, W.,
U. Krusch,
G. Engel,
N. Klijn,
G. Smit, and K. J. Heller.
1997.
The microflora of Tilsit cheese. Part 1. Variability of the smear flora.
Nahrung
41:208-212[CrossRef].
|
| 7.
|
Breiter, J.,
H. Metz, and J. Grigo.
1975.
Staphylococcal micrococcins. II. Isolation, purification and identification.
Arzneimittelforschung
25:1244-1248[Medline].
|
| 8.
|
Brookes, P.,
A. T. Fuller, and J. Walker.
1957.
Chemistry of micrococcin P. Part I.
J. Chem. Soc.
1957:689-699[CrossRef].
|
| 9.
|
Bycroft, B. W., and M. S. Gowland.
1978.
The structures of the highly modified peptide antibiotics micrococcin P1 and P2.
J. Chem. Soc. Chem. Commun.
1978:256-258[CrossRef].
|
| 10.
|
Carminati, D.,
E. Neviani,
G. Ottogalli, and G. Giraffa.
1999.
Use of surface-smear bacteria for inhibition of Listeria monocytogenes on the rind of smear cheese.
Food Microbiol.
16:29-36[CrossRef].
|
| 11.
|
Carnio, M. C.,
I. Eppert, and S. Scherer.
1999.
Analysis of the bacterial surface ripening flora of German and French smeared cheeses with respect to their anti-listerial potential.
Int. J. Food Microbiol.
47:89-97[CrossRef][Medline].
|
| 12.
|
Cundliffe, E., and J. Thompson.
1981.
Concerning the mode of action of micrococcin upon bacterial protein synthesis.
Eur. J. Biochem.
118:47-52[Medline].
|
| 13.
|
Dean, B. M.,
M. P. V. Mijovic, and J. Walker.
1961.
Chemistry of micrococcin P. Part IV. Racemisation of 2-(1-amino-2-methylpropyl)thiazole-4-carboxylic acid, and related studies.
J. Chem. Soc.
1961:3394-3400[CrossRef].
|
| 14.
|
Ennahar, S.,
O. Assobhei, and C. Hasselmann.
1998.
Inhibition of Listeria monocytogenes in a smear-surface soft cheese by Lactobacillus plantarum WHE92, a pediocin AcH producer.
J. Food Prot.
61:186-191[Medline].
|
| 15.
|
Eppert, I.,
N. Valdés-Stauber,
H. Götz,
M. Busse, and S. Scherer.
1997.
Growth reduction of Listeria spp. caused by undefined industrial red smear cheese cultures and bacteriocin producing Brevibacterium linens as evaluated in situ on soft cheese.
Appl. Environ. Microbiol.
63:4812-4817[Abstract].
|
| 16.
|
Fuller, A. T.
1955.
A new antibiotic of bacterial origin.
Nature
175:722.
|
| 17.
|
Garcia, E.,
M. De Paz,
P. Gaya,
M. Medina, and M. Nunez.
1997.
Inhibition of Listeria innocua in Manchego cheese by bacteriocin-producing Enterococcus faecalis INIA4.
Milchwissenschaft
52:667-670.
|
| 18.
|
Giraffa, G.,
N. Picchioni,
E. Neviani, and D. Carminati.
1995.
Production and stability of an Enterococcus faecium bacteriocin during Taleggio cheese-making and ripening.
Food Microbiol.
12:301-307[CrossRef].
|
| 19.
|
Grosenick, H., and V. Schurig.
1997.
Enantioselective capillary gas chromatography and capillary supercritical fluid chromatography on an immobilized -cyclodextrin derivative.
J. Chromatogr. A
761:181-193[CrossRef].
|
| 20.
|
Heatley, N. G., and H. M. Doery.
1951.
The preparation and some properties of purified micrococcin.
Biochem. J.
50:247-253.
|
| 21.
|
Hug-Michel, Ch.,
S. Barben, and U. Kaufmann.
1989.
Hemmumng von Listeria spp. durch Mikroorganismen aus der Rinde von Rotschmiereweichkäsen.
Schweiz. Milchwirtsch. Forsch.
18:46-49.
|
| 22.
|
Irlinger, F.,
A. Morvan,
N. El-Solh, and J. L. Bergere.
1997.
Taxonomic characterization of coagulase-negative staphylococci in ripening flora from traditional French cheese.
Syst. Appl. Microbiol.
20:319-328.
|
| 23.
|
Jack, R.,
F. Götz, and G. Jung.
1997.
Lantibiotics, p. 323-368.
In
H.-J. Rehm, and G. Reed (ed.), Biotechnology, vol. 7. Verlag Chemie, Weinheim, Germany.
|
| 24.
|
Jack, R. W.,
G. Bierbaum, and H.-G. Sahl.
1998.
Lantibiotics and related peptides.
Springer, Berlin, Germany.
|
| 25.
|
James, M. N. G., and K. J. Watson.
1966.
Chemistry of micrococcin P. Part IX. The crystal and molecular structure of micrococcinic acid bis-4-bromoanilide.
J. Chem. Soc. C.
1966:1361-1371[CrossRef].
|
| 26.
|
Jung, G., and H.-G. Sahl (ed.).
1991.
Nisin and novel lantibiotics.
Escom, Leiden, Germany.
|
| 27.
|
Klaenhammer, T. R.
1993.
Genetics of bacteriocins produced by lactic acid bacteria.
FEMS Microbiol. Rev.
12:39-86[Medline].
|
| 28.
|
Maisnier-Patin, S., and J. Richard.
1995.
Activity and purification of Linenscin OC2, an antibacterial substance produced by Brevibacterium linens OC2, an orange cheese coryneform bacterium.
Appl. Environ. Microbiol.
61:1847-1852[Abstract].
|
| 29.
|
Maisnier-Patin, S.,
N. Deschamps,
S. R. Tatini, and J. Richard.
1992.
Inhibition of Listeria monocytogenes in Camembert cheese made with a nisin-producing starter.
Lait
72:249-263[CrossRef].
|
| 30.
|
Martin, F.,
K. Friedrich,
F. Beyer, and G. Terplan.
1995.
Antagonistische Wirkung von Brevibacterium linens-Stämmen gegen Listerien.
Archiv für Lebensmittelhygiene
46:1-24.
|
| 31.
|
Meugnier, H.,
M. Bes,
C. Vernozy-Rozand,
C. Mazuy,
Y. Brun,
J. Freney, and J. Fleurette.
1996.
Identification and ribotyping of Staphylococcus xylosus and Staphylococcus equorum strains isolated from goat milk and cheese.
Int. J. Food Microbiol.
31:325-331[CrossRef][Medline].
|
| 32.
|
Mijovic, M. P. V., and J. Walker.
1960.
Chemistry of micrococcin P. Part II.
J. Chem. Soc. C.
1960:909-916.
|
| 33.
|
Nunez, M.,
J. L. Rodriguez,
E. Garcia,
P. Gaya, and M. Medina.
1997.
Inhibition of Listeria monocytogenes by enterocin 4 during the manufacture and ripening of Manchego cheese.
J. Appl. Microbiol.
83:671-677[CrossRef][Medline].
|
| 34.
|
Okumura, K.,
A. Ito,
D. Yoshioka, and C. Shin.
1998.
Total synthesis of macrocyclic antibiotic micrococcin P1.
Heterocycles
48:1319-1324.
|
| 35.
|
Otaka, T., and A. Kaji.
1974.
Micrococcin: acceptor-site specific inhibitor of protein synthesis.
Eur. J. Biochem.
50:101-106[Medline].
|
| 36.
|
Pucci, M. J.,
E. R. Vedamuthu,
B. S. Kunka, and P. A. Vandenbergh.
1988.
Inhibition of Listeria monocytogenes by using bacteriocin PA-1 produced by Pediococcus acidilactici PAC1.0.
Appl. Environ. Microbiol.
54:2349-2353[Abstract/Free Full Text].
|
| 37.
|
Rodríguez, M.,
F. Núnez,
J. J. Córdoba,
C. Sanabria,
E. Bermúdez, and M. A. Asensio.
1994.
Characterization of Staphylococcus spp. and Micrococcus spp. isolated from Iberian ham throughout the ripening process.
Int. J. Food Microbiol.
24:329-335[CrossRef][Medline].
|
| 38.
|
Rogers, M. J.,
E. Cundliffe, and T. F. McCutchan.
1998.
The antibiotic micrococcin is a potent inhibitor of growth and protein synthesis in the malaria parasite.
Antimicrob. Agents Chemother.
42:715-716[Abstract/Free Full Text].
|
| 39.
|
Rosendahl, G., and S. Douthwaite.
1994.
The antibiotics micrococcin and thiostrepton interact directly with 23S rRNA nucleotides 1067A and 1095A.
Nucleic Acids Res.
22:357-363[Abstract/Free Full Text].
|
| 40.
|
Ryser, E. T.,
S. Maisnier-Patin,
J. J. Gratadoux, and J. Richard.
1994.
Isolation and identification of cheese-smear bacteria inhibitory to Listeria spp.
Int. J. Food Microbiol.
21:237-246[CrossRef][Medline].
|
| 41.
|
Sahl, H. G.
1994.
Staphylococcin 1580 is identical to the lantibiotic epidermin: implications for the nature of bacteriocins from gram-positive bacteria.
Appl. Environ. Microbiol.
60:752-755[Abstract/Free Full Text].
|
| 42.
|
Sahl, H. G., and H. Brandis.
1981.
Production, purification and chemical properties of an anti-staphylococcal agent produced by Staphylococcus epidermidis.
J. Gen. Microbiol.
127:377-384[Abstract/Free Full Text].
|
| 43.
|
Schleifer, K. H.,
R. Kilpper-Bälz, and L. A. Devriese.
1984.
Staphylococcus arlettae sp. nov., S. equorum sp. nov., and S. kloosii sp. nov.: three new coagulase-negative, novobiocin-resistant species from animals.
Syst. Appl. Microbiol.
5:501-509.
|
| 44.
|
Schnell, N.,
K.-D. Entian,
U. Schneider,
F. Götz,
H. Zähner,
R. Kellner, and G. Jung.
1988.
Prepeptide sequence of epidermin, a ribosomally synthesized polypeptide antibiotic containing four sulphide-rings.
Nature
333:276-278[CrossRef][Medline].
|
| 45.
|
Smith, I.,
D. Weiss, and S. Pestka.
1976.
A Micrococcin resistant mutant of Bacillus subtilis: localization of resistance to the 50S subunit.
Mol. Gen. Genet.
144:231-233[CrossRef][Medline].
|
| 46.
|
Spedding, G., and E. Cundliffe.
1984.
Identification of the altered ribosomal component responsible for resistance to micrococcin in mutants of Bacillus megaterium.
Eur. J. Biochem.
140:453-459[Medline].
|
| 47.
|
Stecchini, M. L.,
V. Aquili, and I. Sarais.
1995.
Behaviour of Listeria monocytogenes in Mozarella cheese in presence of Lactococcus lactis.
Int. J. Food Microbiol.
25:301-310[CrossRef][Medline].
|
| 48.
|
Su, T. L.
1948.
Micrococcin, an antibacterial substance formed by a strain of Micrococcus.
Brit. J. Exp. Pathol.
29:473-481[Medline].
|
| 49.
|
Sulzer, G., and M. Busse.
1991.
Growth inhibition of Listeria spp. on camembert cheese by bacteria producing inhibitory substances.
Int. J. Food Microbiol.
14:287-289[CrossRef][Medline].
|
| 50.
|
Valdés-Stauber, N.,
H. Götz, and M. Busse.
1991.
Antagonistic effects of coryneform bacteria from red smear cheese against Listeria species.
Int. J. Food Microbiol.
13:119-130[CrossRef][Medline].
|
| 51.
|
Valdés-Stauber, N., and S. Scherer.
1994.
Isolation and characterization of Linocin M18, a bacteriocin produced by Brevibacterium linens.
Appl. Environ. Microbiol.
60:3809-3814[Abstract/Free Full Text].
|
| 52.
|
Valdés-Stauber, N., and S. Scherer.
1996.
Nucleotide sequence and taxonomical distribution of the bacteriocin gene lin cloned from Brevibacterium linens M18.
Appl. Environ. Microbiol.
62:1283-1286[Abstract].
|
| 53.
|
Valdés-Stauber, N.,
S. Scherer, and H. Seiler.
1997.
Identification of yeasts and coryneform bacteria from the surface microflora of brick cheeses.
Int. J. Food Microbiol.
34:115-129[CrossRef][Medline].
|
| 54.
|
Walker, J.,
A. Olesker,
L. Valente,
R. Rabanal, and G. Lukacs.
1977.
Total structure of the polythiazole-containing antibiotic micrococcin P. A 13C nuclear magnetic resonance study.
J. Chem. Soc. Chem. Commun.
1977:706-708[CrossRef].
|
| 55.
|
Wan, J.,
K. Harmark,
B. E. Davidson,
A. J. Hillier,
J. B. Gordon,
A. Wilcock,
M. W. Hickey, and M. J. Coventry.
1997.
Inhibition of Listeria monocytogenes by piscicolin 126 in milk and Camembert cheese manufactured with a thermophilic starter.
J. Appl. Microbiol.
82:273-280[CrossRef][Medline].
|
Applied and Environmental Microbiology, June 2000, p. 2378-2384, Vol. 66, No. 6
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Goerges, S., Aigner, U., Silakowski, B., Scherer, S.
(2006). Inhibition of Listeria monocytogenes by Food-Borne Yeasts. Appl. Environ. Microbiol.
72: 313-318
[Abstract]
[Full Text]
-
Maoz, A., Mayr, R., Scherer, S.
(2003). Temporal Stability and Biodiversity of Two Complex Antilisterial Cheese-Ripening Microbial Consortia. Appl. Environ. Microbiol.
69: 4012-4018
[Abstract]
[Full Text]
-
Loessner, M., Guenther, S., Steffan, S., Scherer, S.
(2003). A Pediocin-Producing Lactobacillus plantarum Strain Inhibits Listeria monocytogenes in a Multispecies Cheese Surface Microbial Ripening Consortium. Appl. Environ. Microbiol.
69: 1854-1857
[Abstract]
[Full Text]